evidence: Patients treated with PRM (24 weeks) had significantly better cognitive performance than those treated with placebo, as measured by the IADL (P=0.004) and MMSE (P=0.044)
intervention: Prolonged-release melatonin
comparator: Placebo
outcome: MMSE cognitive performance 